J Rheumatol 2021;doi:10.3899/jrheum.200352
In the Methods section, the acronym for “N-terminal pro B-type natriuretic peptide” should be “NT-proBNP.” In the Discussion, reference 19 was cited in the following sentence: “Although there are many reports showing cell infiltration into various organs (e.g., kidney, skin, and lung)….” The studies cited should be references 19–22. The subsequent citations for references 23 and 24 were out of order and should be reversed. The correct order of references is (23) Watanabe T, Takahashi Y, Hirabayashi K, Tomaru U, Machida M. Acute fulminant myocarditis in a patient with primary Sjögren’s syndrome. Scand J Rheumatol 2019;48:164-5; and (24) Voulgarelis M, Tzioufas AG. Pathogenetic mechanisms in the initiation and perpetuation of Sjögren’s syndrome. Nat Rev Rheumatol 2010;6:529-37.
This correction applies to the First Release published online on January 15 and the March print edition. The correct information appears online and in the June 2021 print edition.
- Copyright © 2021 by the Journal of Rheumatology